Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23473944 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL25177337 | 0.86 | ALDH1A1 (0.34) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL19024090 | 0.85 | ALDH1A1 (0.41) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL7101062 | 0.85 | ALDH1A1 (0.38) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL9068703 | 0.80 | ALDH1A1 (0.40) | ALDH1A1MMP8LMNAHSD17B10HDAC4 | |
| SCHEMBL2319054 | 0.80 | ALDH1A1 (0.40) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL1770642 | 0.78 | ALDH1A1 (0.39) | ALDH1A1MMP8LMNAHSD17B10HDAC4 | |
| SCHEMBL141446 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HPGDMMP8LMNAHSD17B10 | |
| SCHEMBL18643783 | 0.77 | SMN1; SMN2 (0.39) | ALDH1A1HPGDPOLBKMT2A | |
| SCHEMBL290478 | 0.77 | ALDH1A1 (0.37) | ALDH1A1MMP8LMNAHSD17B10HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056539-A4 | NICKEL DIIMINE CATALYSTS WITH METHYLALUMOXANE AS COCATALYST, METHOD OF POLYMERIZATION OF OLEFINS THEREWITH AND POLYMERS PRODUCED | CONOCOPHILLIPS CO (US) | 2005-01-26 | — | — | EP | claimed |
| US-6821920-B2 | DIIMINE NICKEL COMPLEXES CONTAINING ACETYLACETONATE, HEXAFLUOROACETYLACETONATE, AND/OR HALOGEN LIGANDS FOR SLURRY POLYMERIZATION OF ALPHA-OLEFINS | PHILLIPS PETROLEUM COMPANY | 2004-11-23 | — | — | US | claimed |
| US-20030134996-A1 | Polymerization catalysts and processes therefor | PHILLIPS PETROLEUM COMPANY (US) | 2003-07-17 | — | — | US | claimed |
| US-6521727-B2 | Slurry polymerization reactor contains ethylene monomer, heterogenous catalyst comprising methylaluminoxane and diimine nickel complexes; for producing high molecular weight polymers from olefins | PHILLIPS PETROLEUM COMPANY | 2003-02-18 | — | — | US | claimed |
| US-6479422-B1 | CATALYSTS SELECTED FROM THE GROUP CONSISTING OF DIIMINE NICKEL (II) COMPLEXES AND DIIMINE PALLADIUM (II) COMPLEXES | PHILLIPS PETROLEUM COMPANY | 2002-11-12 | — | — | US | claimed |
| US-20020016426-A1 | Polymerization catalysts and processes therefor | EILERTS NANCY W (US) | 2002-02-07 | — | — | US | claimed |
| US-6291608-B1 | CONTACTING MONO-1-OLEFIN IN POLYMERIZATION ZONE, UNDER POLYMERIZATION CONDITIONS, WITH A DUAL CATALYST SYSTEM COMPRISING METALLOCENE CATALYST AND COCATALYST AND SECOND CATALYST COMPRISING DIIMINE NICKEL COMPLEX; RECOVERING | PHILLIPS PETROLEUM COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-1056539-A1 | NICKEL DIIMINE CATALYSTS WITH METHYLALUMOXANE AS COCATALYST, METHOD OF POLYMERIZATION OF OLEFINS THEREWITH AND POLYMERS PRODUCED | Phillips Petroleum Company (US) | 2000-12-06 | — | — | EP | claimed |
| WO-1999032226-A1 | NICKEL DIIMINE CATALYSTS WITH METHYLALUMOXANE AS COCATALYST, METHOD OF POLYMERIZATION OF OLEFINS THEREWITH AND POLYMERS PRODUCED | PHILLIPS PETROLEUM COMPANY (US) | 1999-07-01 | — | — | WO | claimed |
| US-12378200-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ORSOBIO, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250145572-A1 | Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors | ORSOBIO INC (US) | 2025-05-08 | — | — | US | disclosed |
| EP-4434982-A1 | (S)-2-(2-METHYLAZETIDIN-1-YL)PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2024-09-25 | — | — | EP | disclosed |
| EP-4374877-A2 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-29 | — | — | EP | disclosed |
| EP-3928779-B1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-03-06 | — | — | EP | disclosed |
| EP-0396250-A1 | Pyrimidinone derivatives | ZENECA LIMITED (GB) | 1990-11-07 | — | — | EP | disclosed |
| US-4962024-A | ADDING SECOND ENZYME AND BLOCKED FLUOROKETONE INHIBITOR OF THE SECOND ENZYME | BECTON, DICKINSON AND COMPANY (US) | 1990-10-09 | — | — | US | disclosed |
| US-4835099-A | Signal enhancement in immunoassay by modulation of enzymatic catalysis | BECTON, DICKINSON AND COMPANY (US) | 1989-05-30 | — | — | US | disclosed |
| EP-0271731-A2 | Signal enhancement in immunoassay by inhibition of enzymatic catalysis | Becton, Dickinson and Company (US) | 1988-06-22 | — | — | EP | disclosed |
| EP-0195212-A2 | Novel peptidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-09-24 | — | — | EP | disclosed |
| US-4103256-A | BLUE-GREEN TO NEAR ULTRAVIOLET | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378200-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ALDH7A1, ACMSD, AMD1 | ALDH1A1 370/4885HPGD 311/4885MMP8 2099/4885 |
| US-20250145572-A1 | Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors | ACMSD, ALDH7A1, ALAD | ALDH1A1 271/4885HPGD 395/4885MMP8 1973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.